Clinical ink announces selection as finalist for 2025 Prix Galien USA, “Best Digital Health Solution”
GlucoseReady™ selected as finalist for “Best Digital Health Solution”.
Press Release
Clinical ink Launches Global Patient Advisory Board to Ensure Engagement in Clinical Technologies
Members from multiple therapeutic areas will incorporate the patient voice into clinical trial technology design.
Clinical ink Launches TrialLens™: An AI-Powered Operations Dashboard for eCOA and Connected Device Trials
AI tool provides real time eCOA and connected device operational data insights.
Clinical ink announces exclusive clinical trial license for the SPUR™ AI-enabled Digital Engagement and Retention Solution
Industry-leading behavioral science tool SPUR™ is validated to predict adherence and will be offered through the Clinical ink technology platform
Clinical ink Announces the Promotion of John Pappadakis to Chief Commercial Officer and Megan Petrylak to Chief Operating Officer
Clinical ink, a global life science technology company, announces the promotion of John Pappadakis from EVP, Global Business Development to Chief Commercial Officer and Megan Petrylak from EVP, Clinical Operations to Chief Operating Officer.
Clinical ink announces EDCXtra™ : An integrated web-based EDC, DDC and eCOA platform
Clinical ink announces EDCXtra: An integrated web-based EDC, DDC and eCOA platform.
Clinical ink announces EDCXtra™ : An integrated web-based EDC, DDC and eCOA platform Read More...
Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer
Clinical ink announced the appointment of Dr. Nicholas Alp as Chief Medical Officer will lead the creation of innovative solutions and commercial strategies for clinical trial technology based on his experience as an interventional cardiologist and clinical trialist.
Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer Read More...
Clinical ink announces GlucoseReady™
Clinical ink announces an integrated suite of eClinical tools for cardiometabolic clinical trials.
Clinical ink announces GlucoseReady™ Read More...
Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™
Clinical ink is expanding its patient engagement suite with the inclusion of the SPUR™ behavioral diagnostic tool created by Observia.
Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™ Read More...
Clinical ink Introduces Breakthrough Solution to Drastically Reduce Study Build Timelines
Clinical ink is setting a new industry benchmark in advancing study build timelines. Harnessing the power of the latest eCOA technology, Clinical ink can now reduce study build timelines to as little as 10 days.
Clinical ink Enhances Data Management Services, and Announces Senior Hires in Data Management and Data Integrity
Clinical ink, a global life science technology company, announces the appointment of Jeff Bock, Vice President of Data Management and Tom Haag, Vice President of Data Quality Control.
Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical ink announced the appointment of Andrew Kraus as Chief Technology Officer who will lead the development of the company’s expanding technology portfolio to support clinical trials.
Clinical ink Appoints Andrew Kraus as Chief Technology Officer Read More...
